Pricing revision to cost Indian pharma $160 mn

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 25 Jun, 2013

Mumbai: The pharmaceutical industry will be widely impacted after India's National Pharmaceutical Pricing Authority (NPP...Read more

US antidepressant market slides down by 4%: report

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 14 Oct, 2013

Singapore: Antidepressant market in US, that peaked at USD12 billion in 2008, has lost USD2.6 billion due to expired pat...Read more

Australia's Starpharma develops Zika-proof condoms for athletes ahead of Rio Olympics

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2016

Australia's Starpharma Holdings Ltd and Ansell Limited have announced that the Australian Olympic team will be provided ...Read more

Celgene settles litigation with India's Natco

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Dec, 2015

Singapore: US based Celgene has settled the litigation with India's Natco Pharma, Natco's US partner, Arrow Internationa...Read more

Self monitoring diabetes market to reach $358 mn

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

Singapore: Three quarters of the population of China and India are diabetic. This translates to a patient pool of nearly...Read more

Do India's bad quality drugs end up in Africa?

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2014

Singapore: According to a research conducted by the National Bureau of Economic Research, some generic drugs sent from I...Read more

Will Japan be able to reduce its generic drug prices?

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 21 May, 2013

The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the ...Read more

Daiichi Sankyo to commercialize AstraZeneca's nasal influenza vaccine in Japan

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Sep, 2015

The global biologics research and development arm of AstraZeneca, MedImmune LLC, has entered into an exclusive license a...Read more

Mylan signs a settlement agreement with OSI Pharma

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

Singapore: US generics major Mylan has entered into a settlement agreement with OSI Pharmaceuticals, a subsidiary of Jap...Read more

India bans pain killer 36 years after the US did so

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Jun, 2013

New Delhi: The Indian health ministry has banned the sale of three medicines after learning about the health risks assoc...Read more

Beximco Pharma enters EU market

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2013

Singapore: Beximco Pharmaceuticals, a manufacturer of generic pharmaceutical products and active pharmaceutical ingredie...Read more

Glenmark's new generic gets FDA nod

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2015

Singapore: Glenmark Pharmaceuticals(Glenmark) has been granted final approval by the United States Food & Drug Admin...Read more

Amneal pharma to acquire Actavis Australia's generic business

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2015

Singapore: US-based Amneal pharmaceuticals announced the acquisition of Actavis pharmaceuticals' generic business in Aus...Read more

ANI pharma, IDT Australia to commercialize US generic drugs

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Aug, 2015

Singapore: ANI Pharmaceuticals, a global specialty pharmaceutical company recently announced collaboration with IDT Aust...Read more

Brickell Biotech-Kaken Pharma to co-develop dermatology drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2015

Brickell Biotech Inc., a US-based clinical-stage pharmaceutical company has signed an exclusive license and development ...Read more

Lupin scouts for acquisitions across the world

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

Singapore: Indian drug major Lupin Pharmaceuticals is set to expand its global footprint by scouting for acquisitions ac...Read more

US rheumatoid arthritis market to reach $9.3 bn by 2020'

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2015

Singapore: US treatment market for rheumatoid arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9...Read more

BioSpectrum announces the hits and misses of 2013

Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2014

Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase i...Read more